On Wednesday, March 27, 2013, the first group of mass media representatives visited Farmak plant. The event was held within the framework of the project for the journalists “Excursions to Farmak’s production sites”.
The journalists visited the workshop for liquid dosage forms. There they were demonstrated the systems of water and air treatment, process of bottling and packing of nasal spray (in glass vials) and eye drops (in plastic vials). The visitors could observe the work of operators at Pharmasulins production line.
Farmak’s specialists told the journalists how the finished dosage forms manufacturing process is organized, what requirements are to the arrangement of the production premises and personnel involved in the manufacturing process.
Let you remind that the excursions to Farmak’s production sites take place on Wednesdays. In order to visit Farmak’s production sites you are to submit the application form to e-mail: M.Lavruh@farmak.ua. In the application form you are to specify your first name, last name, the name of mass media you represent, position and contact information.
As the groups are formed we shall contact you and inform of the date and time of excursion.
For more details, please, contact the supervisor of the project “Excursions to Farmak’s production sites”, chief of Farmak’s PR sector, Lavrukh Marko: tel.: (044) 496-8779, (067) 464-9794; е-mail: M.Lavruh@farmak.ua.
Farmak, as a member of the European Generic Medicines Association (EGA) – Medicines for Europe – and the Association of “Manufacturers of Drugs of Ukraine” (the AMDU), advocates for the creation of a coordination group at the Office of the President of Ukraine to prevent a shortage of medicines in Ukraine during the pandemic. […]
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]